XML 92 R46.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Shareholders' capital (Tables)
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Number of Common Shares
Number of common shares 
 
 
2019
 
2018
Common shares, beginning of year
 
488,851,433

 
431,765,935

Public offering (a)(i) and (a)(ii)
 
28,009,341

 
50,041,624

Dividend reinvestment plan (a)(iii)
 
6,068,465

 
5,880,843

Exercise of share-based awards (c)
 
1,274,655

 
1,106,105

Conversion of convertible debentures (note 12(h))
 
19,429

 
56,926

Common shares, end of year
 
524,223,323

 
488,851,433


Schedule of Shares Issued and Outstanding
The Company has the following Series A and Series D preferred shares issued and outstanding as at December 31, 2019 and 2018:
Preferred shares
Number of shares
 
Price per share
 
Carrying amount C$
 
Carrying amount $
Series A
4,800,000

 
C$
25

 
C$
116,546

 
$
100,463

Series D
4,000,000

 
C$
25

 
C$
97,259

 
$
83,836

 
 
 
 
 


 
$
184,299


Share-Based Compensation Expense
For the year ended December 31, 2019, APUC recorded $10,553 (2018 - $9,458) in total share-based compensation expense detailed as follows: 
 
2019
 
2018
Share options
$
1,288

 
$
2,054

Director deferred share units
798

 
714

Employee share purchase
322

 
312

Performance and restricted share units
8,145

 
6,378

Total share-based compensation
$
10,553

 
$
9,458






Fair Value of Share Options Granted
The following assumptions were used in determining the fair value of share options granted: 
 
2019
 
2018
Risk-free interest rate
1.9
%
 
2.1
%
Expected volatility
20
%
 
21
%
Expected dividend yield
4.3
%
 
4.8
%
Expected life
5.50 years

 
5.50 years

Weighted average grant date fair value per option
C$
1.66

 
C$
1.41












Stock Option Activity
Share option activity during the years is as follows: 
 
Number of
awards
 
Weighted
average
exercise
price
 
Weighted
average
remaining
contractual
term
(years)
 
Aggregate
intrinsic
value
Balance, January 1, 2018
6,738,856

 
C$
11.18

 
6.32

 
C$
19,380

Granted
1,166,717

 
12.80

 
8.00

 

Exercised
(1,589,211
)
 
10.66

 
5.02

 
5,059

Forfeited
(23,720
)
 
12.80

 

 

Balance, December 31, 2018
6,292,642

 
C$
11.61

 
5.75

 
C$
13,342

Granted
1,113,775

 
14.96

 
8.00

 

Exercised
(3,882,505
)
 
11.23

 
4.45

 
6,225

Forfeited

 

 

 

Balance, December 31, 2019
3,523,912

 
C$
13.09

 
5.87

 
C$
18,609

Exercisable, December 31, 2019
1,735,241

 
C$
12.57

 
5.43

 
C$
14,559


Performance Stock Units .
A summary of the PSUs and RSUs follows: 
 
Number of awards
 
Weighted
average
grant-date
fair value
 
Weighted
average
remaining
contractual
term (years)
 
Aggregate
intrinsic
value
Balance, January 1, 2018
955,028

 
C$
12.30

 
1.84

 
C$
13,428

Granted, including dividends
791,524

 
12.41

 
2.00

 
10,098

Exercised
(285,551
)
 
10.02

 

 
3,691

Forfeited
(68,869
)
 
13.02

 

 

Balance, December 31, 2018
1,392,132

 
C$
12.75

 
1.60

 
C$
19,114

Granted, including dividends
1,471,442

 
14.69

 
2.00

 
16,302

Exercised
(344,340
)
 
11.55

 

 
5,148

Forfeited
(107,191
)
 
13.84

 

 

Balance, December 31, 2019
2,412,043

 
C$
14.00

 
1.86

 
C$
44,309

Exercisable, December 31, 2019
743,787

 
C$
13.21

 

 
C$
13,663

 
(v)
Bonus deferral RSUs
During 2018, the Company introduced a new bonus deferral RSU program to certain of its employees. Eligible employees have the option to receive a portion or all of their annual bonus payment in RSUs in lieu of cash. The RSUs provide for settlement in shares, and therefore these options are accounted for as equity awards. The RSUs granted are 100% vested and therefore, compensation expense associated with RSUs is recognized immediately upon issuance.







13.
Shareholders’ capital (continued)
(c)
Share-based compensation (continued)
(vi)
Bonus deferral RSUs
A summary of the bonus deferral RSUs follows